Biogen (BIIB) on Watch Amid Renewed Chatter

August 8, 2016 11:30 AM EDT

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Biogen (NASDAQ: BIIB) was on watch amid renewed takeover chatter. Chatter suggests Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ) may also be interested in the company. The source of the rumor was said to be DealReporter.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment